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Abstract
Pathologic conditions impair bone homeostasis. The transcription factor NF-kB regulates bone homeostasis and is central to
bone pathologies. Whereas contribution of NF-kB to heightened osteoclast activity is well-documented, the mechanisms
underlying NF-kB impact on chondrocytes and osteoblasts are scarce. In this study, we examined the effect of constitutively
active IKK2 (IKK2ca) on chondrogenic and osteogenic differentiation. We show that retroviral IKK2ca but not GFP, IKK2WT, or
the inactive IKK2 forms IKK2KM and IKK2SSAA, strongly suppressed osteogenesis and chondrogenesis, in vitro. In order to
explore the effect of constitutive NF-kB activation on bone formation in vivo, we activated this pathway in a conditional
fashion. Specifically, we crossed the R26StopIKK2ca mice with mice carrying the Col2-cre in order to express IKK2ca in
osteoblasts and chondrocytes. Both chondrocytes and osteoblasts derived from Col2Cre/IKK2ca expressed IKK2ca. Mice
were born alive yet died shortly thereafter. Histologically, newborn Col2Cre+/RosaIKK2ca heterozygotes (Cre+IKK2ca_w/f
(het)) and homozygotes (Cre+IKK2ca_f/f (KI)) showed smaller skeleton, deformed vertebrate and reduced or missing digit
ossification. The width of neural arches, as well as ossification in vertebral bodies of Cre+IKK2ca_w/f and Cre+IKK2ca_f/f, was
reduced or diminished. H&E staining of proximal tibia from new born pups revealed that Cre+IKK2ca_f/f displayed
disorganized hypertrophic zones within the smaller epiphysis. Micro-CT analysis indicated that 4-wk old Cre+IKK2ca_w/f has
abnormal trabecular bone in proximal tibia compared to WT littermates. Mechanistically, ex-vivo experiments showed that
expression of differentiation markers in calvarial osteoblasts derived from newborn IKK2ca knock-in mice was diminished
compared to WT-derived cells. In situ hybridization studies demonstrated that the hypertrophic chondrocyte marker type-X
collagen, the pre-hypertrophic chondrocyte markers Indian hedgehog and alkaline phosphatase, and the early markers
Aggrecan and type-II collagen were reduced in Cre+IKK2ca_w/f and Cre+IKK2ca_f/f mice. Altogether, the in-vitro, in vivo
and ex-vivo evidence suggest that IKK2ca perturbs osteoblast and chondrocyte maturation and impairs skeletal
development.
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Introduction
Bone is constantly remodeled temporally and spatially by
precise regulatory mechanisms that coordinate bone formation
and bone resorption [1–3]. Accrual of bone mass is determined by
net balance between bone formation and bone resorption.
Conversely, imbalance between bone resorption and bone
formation leads to skeletal deformities such as bone loss (all forms
of osteoporosis, osteopenia, etc) or excessive bone formation often
non-remodelled as evident in various forms of osteopetrosis [4]. At
the cellular level, mesenchyme-derived osteoblasts lay down
matrix and hematopoietic-derived osteoclast resorb and remodel
the formed bone tissue. Numerous paracrine and autocrine factors
and systems regulate this process [3].
The effect of inflammatory responses on bone health has been
widely described [5–11] and in fact, osteoporosis has been
considered as a co-morbidity in patients suffering from chronic
inflammatory diseases such as rheumatoid arthritis, inflammatory
bowel disease (IBD), colitis, etc. [5–11], which typically present
increased fracture risk. At the cellular level, inflammatory
mediators target the entire milieu of the bone tissue; they promote
differentiation of myeloid cells into osteoclasts to exacerbate bone
resorption and negatively impact bone formation by targeting
mesenchymal and osteoblast cells. The former effect on osteoclasts
has been widely detailed [6,12]. However, the mechanism
underpinning inhibition of bone formation remains vague. In this
regard, numerous clinical case reports correlated high circulating
levels of inflammatory cytokines including TNF, IL-1b, IL-17, IL-
4, IL-6 and others, with the bone phenotype of the subjects [13–
15]. In other studies, elevated levels of the WNT pathway
antagonists sclerostin and DKK1 were reported in animal models
of rheumatoid arthritis [16]. Expression of sclerostin and DKK1
was elevated in synovial tissue from rheumatoid arthritis patients
compared to controls and bone repair was often delayed or
repressed in patients with systemic inflammatory background [17–
19].
The transcription factor NF-kB has been implicated as crucial
mediator of immune/inflammatory responses and required for
skeletal development [20–25]. In this regard, it has been shown
that NF-kB signaling regulates osteoclastogenesis and mediates
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inflammatory bone diseases [26]. IKK2, also known as IKKb, is
required for activation of the classical NF-kB pathway and
mediates the vast majority of inflammatory responses [24,27–30].
Constitutively active IKK2 (in which the activation loop serines
are substituted with glutamic acid) sustains heightened NF-kB
activity and intrinsically recapitulates the inflammatory response
[31–33]. In this regard, we have shown that knock-in of this
constitutively active form of IKK2 in the myeloid lineage in mice
induced systemic osteolysis owing to elevated endogenous
osteoclastogenesis [31]. However, given the ubiquitous expression
of IKK2 in all tissues of mammals, the effect of IKK2 on other
crucial skeletal components/processes such as osteogenesis and
chondrogenesis remains elusive. Few studies suggest that cross-talk
between NF-kB signaling and osteogenesis indeed exists. In fact, a
recent study utilizing dominant negative approach suggests that
IKK2 is a repressor of osteogenesis [34]. Another recent report has
shown that NF-kB inhibits osteogenesis by promoting degradation
of b-catenin, a downstream mediator of WNT signaling [35]. In
other systems, it has been suggested that NF-kB activates Notch
and blocks WNT signaling pathways [36–38]. Despite these
studies, the mechanisms underlying NF-kB regulation of osteo-
genesis remain scant. To gain better appreciation of the
developmental role of IKK2 in skeletal homeostasis and its
osteo-inflammatory role, we examined the effect of constitutively
active IKK2 (resembling sustained inflammatory response) during
mesenchymal and chondrogenic development.
Methods
Mice
Coll2-cre and pROSA-IKK2ca mice have been described
[33,39]. Briefly, the pRosa26-IKK2ca transgenic mice harbor a
cDNA encoding IKK2 containing two serine to glutamate
substitutions in the activation loop of the kinase domain (SSREE),
preceded by a loxP-flanked STOP cassette, into the ubiquitously
expressed ROSA26 locus. We crossed mice carrying this allele to
the Col2-cre mice in order to express IKK2ca in osteoblasts and
chondrocytes. For in vitro studies, a retrovirus expressing IKK2ca
was used to transduce primary osteoblasts and transformed OB/
stromal cells.
Skeletal Analysis and Histology
For skeletal staining, newborn pups were isolated, de-skinned,
eviscerated, and fixed in 95% ethanol overnight. The skeletons
were then stained for 3 days with 0.3% Alcian Blue and 0.3%
Alizarin Red dissolved in 75% ethanol–20% glacial acetic acid.
Thereafter, the skeletons were rinsed with 95% Ethanol for 2 hrs.
Samples were cleared in 1% KOH for 4 days. The skeletons were
subsequently transferred to decreasing concentrations of KOH
(1.6, 1.2, 0.8, and 0.4%) mixed with increasing amounts of glycerol
(20, 40, 60, and 80%) at 1-day intervals. For histology, limbs were
fixed in formalin, decalcified, and embedded in paraffin. Sections
were cut every 6 um and stained with hematoxylin and eosin.
In situ Hybridization
Embryonic tissues were fixed in 10% formalin overnight at
room temperature, then decalcified and embedded in paraffin
prior to sectioning at 6 mm. In situ hybridization was performed by
using digoxigenin-labeled riboprobes as previously described [40].
Type-I a1, type-II and type-X collagen cRNA anti-sense probes
were derived by in vitro transcription.
Retroviral Infection
Retrovirus was generated by transfection of pMX-IKK2ca into
Plat-E packaging cells with Fugene 6. After retroviral infection for
12–24 hours and puromycin selection for 2 days, ST2 cells or
ATDC5 cells were cultured in regular complete medium for an
additional 1 day before harvesting for differentiation assay.
Primary cOB Culture
Calvaria were harvested from neonatal mice pups. Briefly,
calvaria were surgically removed from the skull, sutures were
removed, and adherent tissue material was cleaned by gentle
scrapping using a scalpel, followed by chopping to very small
fragments. Pooled calvaria were subjected to sequential digestions
(15 minutes/digestion) with 0.1% dispase and 0.1% collagenase P
to release cells. After discarding the cells from the first digestion
(heterogeneous population), cells from the next four digestions
were pooled and cultured in a ascorbic acid free-modified essential
medium (a-MEM) containing 10% FBS [41].
ST2 Cell Culture, AP Staining and von Kossa Staining
ST-2 mouse bone marrow stromal cell line (Riken Cell Bank,
Tsukuba, Japan) were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% heat-inactivated fetal
bovine serum (Invitrogen) and antibiotics. ST2 were cultured with
Wnt3a conditioned medium for 2–5 days for osteoblast differen-
tiation. For alkaline phosphatase and von Kossa stainings, cells
were fixed with 10% formalin for 10 min and washed three times
with 10 mM Tris?HCl, pH 7.2. Fixed cells were subjected to
staining for alkaline phosphatase and von Kossa staining. Alkaline
phosphatase was stained with naphthol AS-MX phosphate and
fast blue BB salt (Sigma kit# 85L-2). The von Kossa staining for
calcium was performed as follows. Fixed cells were incubated with
5% silver nitrate for 5 min in daylight, washed twice with H2O,
and then treated with 5% sodium thiosulfate. Mineralized nodules
were counted under a microscope.
ATDC5 Cell Culture and Alcian Blue Staining
ATDC5 cells [42] (Riken Cell Bank, Tsukuba, Japan), derived
from mouse embryonal carcinoma, were cultured in a 1:1 mixture
of Dulbecco’s modified Eagle’s medium and Ham’s F-12
(Cambrex Bio Science Inc, Walkersville, MD) supplemented with
5% fetal bovine serum (Invitrogen), 10 ug/ml human transferrin
(Sigma-Aldrich), 3 X10–8 M sodium selenite (Sigma-Aldrich) at
37uC under 5% CO2. Upon reaching confluence, the cells were
stimulated with 10 ug/ml of bovine insulin (Sigma-Aldrich), and
the medium was changed every other day. Alcian blue (Sigma-
Aldrich), which stains cartilage-like extracellular matrix produced
by mature chondrocytes, was used to evaluate expression of
extracellular matrix by ATDC5 cells. The staining was done after
the cells were rinsed with phosphate-buffered saline, incubated
with 0.1% Alcian blue solution in 0.1 N HCl (pH 1.0) overnight,
and washed three times with phosphate-buffered saline before
macroscopic examination.
Reverse Transcription-polymerase Chain Reaction
Analysis of Osteoblast, Chondrocyte Differentiation
ST2 cells and ATDC5 cells treated for Wnt3a or insulin for the
indicated periods were subjected to RT-PCR with the specific
primers. Osteocalcin (OSC) and aggrecan are osteoblast-specific
secretory protein and extracellular matrix protein in cartilage
respectively. GAPDH was used as internal control.
This study was carried out in strict accordance with the
recommendations in the guide for the Care and Use of Laboratory
NF-kB Regulates Osteogenesis
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Animals of the National Institute of Health. All animals are housed
in the facility at Washington University under the care of trained
technicians and veterinarians. Animals experiencing pain or
discomfort following procedures are treated with analgesics per
approved protocol. Euthanasia is performed by inhalation of
gaseous CO2 in a closed chamber. This method is approved by
the AVMA. All animal work was pre-approved by the animal
committee of Washington University and conducted according to
AVMA guidelines.
Statistical Analysis
Data are expressed as mean 6 SEM unless otherwise indicated.
The data obtained in experiments with multiple treatments were
analyzed using one-way ANOVA followed by post hoc Newman-
Keuls test of significance or student t-test. Qualitative observations
have been represented following triple blind assessments. All
experiments were repeated at least three times and quantitative
data for in vivo data were collected from groups of at least 6 mice
per group.
Results
Constitutive Activation of NF-kB in Osteoblasts,
Chondrocytes and Stromal Cells Inhibits their
Differentiation
Osteoblasts and chondrocytes are derived from mesenchymal
precursor cells and are the principal bone and cartilage forming
cells, respectively. Persistent NF-kB activation is central to
inflammatory responses that impact all components of bone
development. To mimic the impact of inflammatory responses on
osteoblasts, we virally expressed IKK2ca (FLAG-tagged) in
calvarial osteoblasts and demonstrated its expression and activity
(fig. 1A–B) as evident by significant phosphorylation of the
substrate IkB by IKK2ca compared to minimal or absence of IkB
phosphorylation (pIkB) by wild type (WT) or kinase-dead (KD)
IKK2, respectively (1B). Note that IkB phosphorylation coincides
with its degradation (Fig. 1B; lane 2).
To examine the effect of NF-kB activation on their differen-
tiation and maturation, the bone marrow stromal cell line ST2
cells and the chondrogenic cell line ATDC5 were infected with
viral particles expressing constitutively active IKK2 (referred to as
‘‘ca’’), control GFP, wild type IKK2 (WT), kinase dead (KD)
IKK2, and phospho-deficient (SSAA) IKK2. The results indicate
that expression of the stromal cell differentiation marker alkaline
phosphatase and the chondrocyte differentiation marker Alcian
blue are significantly blunted by IKK2ca (ca) (fig. 1C–D). In
contrast, no change was observed with GFP, WT, or SSAA
transduction. Consistently, mRNA expression of alkaline phos-
phatase in ST2 cells and chondrocyte markers (Sox9, Col2A1,
aggrecan) in ATDC were reduced in IKK2ca-infected cells
compared with GFP or IKK2WT-infected cells (Fig. S1).
Mice Expressing IKK2ca Exhibit Abnormal Skeletal
Development
In order to explore the role of constitutive NF-kB activation
during bone formation in vivo, we decided to activate this
pathway in a conditional fashion. We employed the R26Sto-
pIKK2ca mice in which a cDNA encoding IKK2 containing two
serine to glutamate substitutions in the activation loop of the
kinase domain, preceded by a loxP-flanked STOP cassette, was
cloned into the ubiquitously expressed ROSA26 locus [33]. We
crossed mice carrying this allele to the Col2-cre mice in order to
express IKK2ca in chondrocytes, as well as osteoblasts. Both
chondrocytes (not shown) and osteoblasts (fig. 2A) derived from
Cre+IKK2ca_w/f or Cre+IKK2ca_f/f express Flag-tagged
IKK2ca detected by Western blot. Histologically, newborn Cre+
IKK2ca_w/f heterozygotes Cre+IKK2ca_f/f and homozygotes
showed smaller skeleton and deformed vertebrates. Examination
of the appendicular and axial skeleton revealed reduced or missing
digit ossification (arrows and asterisks) in heterozygotes and
homozygotes, respectively (fig. 2C–D). Compared to WT litter-
mates, the width of neural arches as well as ossification in vertebral
bodies of IKK2ca heterozygotes and homozygotes were reduced
or diminished (fig. 2E; arrows). Sternum with ribs showed wider
xiphoid process with two well-separated ossification centers in
newborn IKK2ca heterozygotes and homozygotes (not shown).
Reduced length of scapula in newborn IKK2ca heterozygotes
(2665%) and homozygotes (3964%) was also noted (fig. 2C;
horizontal lines). In addition, sutures and fontanelles were widened
in IKK2ca homozygotes (fig. 2B; arrows, 2D; arrow heads).
IKK2ca homozygote mice died shortly after birth, while
heterozygote mice survived to maturity.
IKK2ca Expression in vivo Dampens Expression of
Chondrogenic and Osteogenic Markers
In order to further characterize the molecular mechanism
underlying the effect of constitutively active IKK2 in the
regulation of osteogenesis and chondrogenesis, we performed in
situ hybridization of several markers for either chondrogenesis or
osteogenesis in new born transgenic mice and control littermates.
Hematoxylin and eosin (H&E) staining of proximal tibia from new
born pups showed that Cre+/RosaIKK2ca homozygotes dis-
played disorganized hypertrophic zones within the smaller
epiphysis (columnar zone) compared to WT littermates (fig. 3A,B;
arrows). We found that the hypertrophic chondrocyte marker
type-X collagen (Col X) was reduced or diminished in IKK2ca
heterozygote or homozygote, compared to WT control (fig. 3A).
The pre-hypertrophic chondrocyte markers Indian hedgehog (Ihh)
and alkaline phosphatase were also significantly reduced or lost in
IKK2ca heterozygote or homozygotes. The early differentiation
markers such as Aggrecan and type-II collagen (Col II) were
reduced, while Sox9 only slightly reduced in IKK2ca homozygote
mice, compared to WT controls (fig. 3A). In all these
circumstance, HE staining showed that there is no obvious cell
loss in cartilage, suggesting that IKK2 suppresses chondrocyte
differentiation. Although Type-I a1(Col I) mRNA remained
unchanged, AP mRNA signal was diminished in osteoblast
derived from IKK2ca homozygote compared to WT controls
(fig. 3A).
Based on the in vivo observation of the widened sutures/
fontanelles, which is not dependent of chondrogenesis, and
diminished AP expression in Col2Cre+/RosaIKK2ca homozy-
gotes, it is possible that constitutive active IKK2 also suppresses
osteoblast differentiation. To address this point, primary osteo-
blasts were isolated from new born IKK2ca transgenic and control
counterparts and cultured them in osteogenic media. Similar to
cultures of ST2 cells retrovirally infected with constitutive active
IKK2, the kinase strongly suppresses primary osteoblast differen-
tiation as shown by alkaline phosphatase staining of cells
stimulated with osteogenic factor Wnt3a (fig. 3C). Real-time
PCR also showed that IKK2ca downregulate Runx2 osteocalcin
(OCN), osteoprotegerin (OPG) and alkaline phosphatase (AP)
mRNA expression in IKK2ca-derived OBs (fig. 3D). In addition,
IKK2ca expression led to increased expression of WNT antago-
nists; sclerostin (SOST) and DKK1, and increased expression of
RANKL (fig. 3D). Both ex vivo and in vitro data demonstrate that
NF-kB Regulates Osteogenesis
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e91421
constitutive active IKKb suppresses osteoblast differentiation and
skew RANKL/OPG ratio toward enhanced osteoclastogenesis.
Expression of IKK2ca Impedes Bone Formation and
Reduces Bone Mineral Density
Inhibition of osteoblast differentiation markers by IKK2ca
suggests that endogenous expression of the kinase in vivo may
negatively impact normal skeletal development. To examine this
possibility, we utilized IKK2ca heterozygous mice, which lived
normally but exhibited moderate ossification defects (fig. 2) at
developmental stages. Micro-CT analysis shows that mature
heterozygous mice exhibited significant low bone mass (BV/
TV), consistent with decreased trabecular thickness (Tb.Th) and
number (Tb.N) and increased trabecular space (Tb.Sp) (fig. 4). To
further establish this phenotype, dynamic bone markers such as
bone formation rate and mineral apposition rate were measured
using bone double labeling approach. The images depicted in
figure 4B show that IKK2ca attenuated bone formation and exerts
its inhibitory effect in an osteoblast-intrinsic fashion. We further
provide preliminary evidence that osteoclast number is elevated in
IKK2ca-expressing mice (Fig. S2), suggesting that bone resorption
by osteoclasts may contribute to this phenotype.
Discussion
Inflammation of bone negatively impacts its integrity and
strength and alters bone-dependent metabolic pathways [21,
43–47]. Therefore, understanding the underlying mechanisms of
this phenomenon in bone cells is critical for establishing
countermeasures. The fact that NF-kB is central mediator of
inflammatory responses positions this family of proteins and
kinases as an attractive target for exploration. NF-kB proteins
regulate numerous physiological and pathological processes,
including the innate- and adaptive-immune responses, cell death
and inflammation. The classical NF-kB pathway is driven by the
activation of IKK2, which stimulates anti-apoptotic, pro-inflam-
matory and proliferative pathways, although pro-apoptotic func-
tions have also been described [23,24]. Furthermore, it has been
reported that IKK2 functions through NF-kB-dependent and
independent pathways. The choice of IKK2ca in our model to
mimic sustained inflammation is based on the fact that activation
of this kinase has been described as the converging point for all
inducers of the canonical NF-kB pathway, which is the principal
pathway that governs inflammatory processes.
In recent studies, we and others have examined the effect of NF-
kB in the myeloid compartment. We demonstrated that consti-
tutive activation of NF-kB led to significant bone loss in mice [31].
In the current study, we turned to examine the effect of active NF-
kB in the mesenchymal compartment. Our results indicate that
constitutive activation of NF-kB pathway using collagen-II cre
knock-in in osteoblasts and chondrocytes perturbed osteogenesis
and chondrogenesis. Considering both facets of NF-kB activation
in myeloid and mesenchymal compartment, this approach nearly
mimics systemic inflammation such as in rheumatoid arthritis
Figure 1. Constitutive activation of NF-kB in osteoblasts, chondrocytes and stromal cells inhibits their differentiation. (A) Calvarial
osteoblasts (cOB) were transduced using retroviral constructs pMX-GFP and pMX-IKK2-ca and incubated for the time points indicated. Western blots
were used to show expression of Flag-tagged IKK2 and b-actin in cOB. (B) Expression of IkB and phospho-IkB in lysates of OBs transduced with pMx-
GFP or the various forms of IKK2 as indicated. (C–D) Calvarial OBs (C), ST2 and ATDC5 cells (D) were infected with GFP, IKK2WT, IKK2ca, IKK2KD, or
IKK2SSAA and incubated for 21 days with 10 ug/ml of bovine insulin (media was changed and supplemented with fresh insulin every 48 hrs). Cells
were then stained with either alkaline phosphatase (ALP) or Alcian blue. Note reduced staining in IKK2ca conditions. Lower left panel (C) depicts
optical density quantification of upper panel. Right panel (D) represents quantification of ST2 cell and ATDC5 staining (not shown) using arbitrary
units expressed as % of control. Experiments were repeated at least three times in triplicate conditions. Asterisk represents p,0.01.
doi:10.1371/journal.pone.0091421.g001
NF-kB Regulates Osteogenesis
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wherein compromised osteoblast activity and exacerbated osteo-
clastogenesis is prevalent at inflammatory sites. Consistent with
this notion, it has been reported that expression levels of several
WNT antagonists are elevated in arthritic synovial fluid further
contributing to inhibition of bone formation[17,48–50]. Our
data establish attenuation of osteogenic differentiation markers
Figure 2. Mice expressing IKK2ca exhibit abnormal skeletal development. (A) cOB cells were harvested form newborn mice, lysed and
subjected to Western blot with Flag (IKK2) and beta-actin antibodies. (B) Neurocranium of Newborn WT, Col2Cre+/IKK2ca heterozygotes (het) and
homozygotes (KI). Sutures and fontanelles are widened in Col2Cre+/IKK2ca homozygotes (asterisk). Arrows (bottom) indicate the unfused and smaller
supraoccipital bone in Col2Cre+/IKK2ca heterozygotes and homozygotes, respectively. Shortened snout in homozygous knock-in (large arrow)
compared with hets and WT littermates. (C–D) Newborn pups were stained with Alcian blue/Alizarin red. Bone is stained red and cartilage blue. Limbs
showed reduced length of scapula in newborn Col2Cre+/IKK2ca heterozygotes and homozygotes (D) Smaller skeleton and deformed vertebrate in
newborn Col2Cre+/IKK2ca heterozygotes (wf) and homozygotes (ff). Reduced or missing digit ossification in Col2Cre+/IKK2ca heterozygotes and
homozygotes respectively (arrows and asterisks). Reduced or diminished ossification in vertebral bodies and skull in knock-in mice is apparent (arrow
heads). (E) Dorsoventral view of vertebra showing reduced width of neural arches as well as reduced or diminished degrees of ossification in vertebral
bodies (arrow) of newborn Col2Cre+/IKK2ca heterozygotes and homozygotes respectively compared to WT littermates.
doi:10.1371/journal.pone.0091421.g002
NF-kB Regulates Osteogenesis
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Figure 3. IKK2ca expression in vivo dampens expression of chondrogenic and osteogenic markers. (A) Hematoxylin and eosin (H&E)
staining of proximal tibia from new born pups. Col2Cre+/IKK2ca heterozygotes and homozygotes displayed disorganization of hypertrophic zones
within the smaller epiphysis compared to WT littermates. In situ detection of type-I a1(Col I) type-II (Col II), type-X collagen (Col X), Alkaline
phosphatase (AP), indian hedgehog (Ihh), Sox 9, and Aggrecan (Agc1) mRNAs in growth plates of femur sections prepared from new born Col2Cre+/
IKK2ca homozygotes, heterozygote and control littermates. Reduced Col I, Col-II, AP positive osteoblast and Col X, Sox9 hypertrophic chondrocytes in
Col2Cre+/IKK2ca heterozygote, compared to WT control is noted. (B) Higher magnification of H&E-stained sections for new born wild type and Cre+
IKK2ca homozygotes. Columnar zones are indicated with arrows (C) Alkaline phosphatase staining of cOB isolated from WT and IKK2ca knock-in mice.
NF-kB Regulates Osteogenesis
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consonant with elevated levels of DKK1 and sclerostin (modeled
in Fig. 5). We speculate that NF-kB-induced genes activate sost and
dkk1 genes leading to higher expression of their products, sclerostin
and DKK1, respectively, which inhibit Wnt signaling in osteo-
blasts (Fig. 5). Ongoing studies in our laboratory are now focused
on investigating the molecular mechanisms underpinning NF-kB-
mediated inhibition of WNT signaling. In this regard, strong
supporting evidence was recently described by Chang et al., [51]
suggesting that NF-kB inhibits osteogenesis by promoting b-
catenin degradation. This study, however, utilized the pleiotropic
cytokine TNF to activate NF-kB and as a result cannot account for
NF-kB-independent effects of the cytokine on osteogenesis.
Although activation of NF-kB is normally transient, chronic or
sustained activation of NF-kB as is the case of our model described
in this study leads to the establishment of inflammatory conditions
through expression of a wide range of mediators including
cytokines, radical oxygen species, and cyclo-oxigenases. This
mode of NF-kB activation is associated with aging and has been
(D) IKK2ca affects the mRNA expression of various osteoblast-differentiation associated genes. cOB were cultured in differentiation media for 9 and 12
days, followed by mRNA isolation and qPCR for various osteoblast differentiation associated gene. While, IKK2ca expression decreases the mRNA
expression of ALP, Runx2 and OCN (asterisk indicates p,0.01), it increases the mRNA expression of DKK1 and SOST which negatively regulates Wnt
signaling. It also increases the RANKL/OPG ratio by increasing the expression of RANKL. Asterisks * and ** represent p,0.01 and 0.05, respectively. All
experiments including the histology and qPCR were repeated 3 times (n = 3).
doi:10.1371/journal.pone.0091421.g003
Figure 4. Expression of IKK2ca impedes bone formation and reduces bone mineral density. (A) Micro-CT analysis of four-week old
Col2Cre+/IKK2ca heterozygote (Het) and WT littermate (n = 6/group). Col2Cre+/IKK2ca heterozygote has reduced trabecular bone in proximal tibia
and femur compared to WT littermate. Quantitation of bone volume (BV) over total volume (TV), trabecular number (Tb.N), trabecular thickness
(Tb.Th.) and trabecular separation (Tb.Sp.) is shown. (B) Bone formation rate - 4-week old mice (n = 6/group) were injected with two consecutive
labels (arrows) of calcein (7 days apart) to measure bone formation rate. Asterisk represents p,0.05.
doi:10.1371/journal.pone.0091421.g004
NF-kB Regulates Osteogenesis
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described as a molecular culprit of inflamm-aging [52]. In this
regard, secondary osteoporosis has been described as a co-
morbidity of numerous low grade systemic inflammatory responses
attending aging individuals. More importantly, a credible link
between efficiency of NF-kB signaling and the level of inflamma-
tion has been established and is regulated by SIRT1 and FoxO,
well-established regulators of aging [53,54]. In fact, it is plausible
that Sirt1 augments bone formation by down regulating NF-kB -
induced SOST expression. Future studies will be required to
confirm the molecular details of this proposition using experimen-
tal models of inflammatory-aging bone loss.
The increase in sclerostin and DKK1 expression levels and
coincidental increase in RANKL/OPG ratio in IKK2ca-express-
ing mice (Fig. 5) is also reminiscent of similar expression profiles of
these factors during bone fractures, suggesting that NF-kB plays a
central role during bone injury and repair. Accordingly, during the
initial phase of bone trauma/fracture a robust local inflammatory
response, highlighted by enhanced levels of NF-kB activity [55],
develops and encompasses recruitment of immune cells including
macrophages to the injury site. At the conclusion of this stage, high
levels of NF-kB are expected to subside and a bone reparative
phase and angiogenesis govern the site. In support of this notion, it
has been suggested that bone formation is often repressed in
patients suffering from rheumatoid arthritis and that DKK1 and
sclerostin (inhibitors of bone formation) were detected in serum of
these patients and other inflammatory conditions [18,19,50,
56,57]. Similarly, bacterially contaminated bone fractures fail to
heal [58], suggesting that bacteria-derived lipopolysaccharides
activate NF-kB in various cells, including osteoclasts and
osteoblasts, and impede repair. Therefore, precise control of the
duration and strength of NF-kB activity are crucial for modulating
and resolving inflammatory osteolysis.
Supporting Information
Figure S1 IKK2ca inhibits mRNA expression of ST2 and
ATDC5 differentiation markers. ST2 and ATDC5 cells were
infected with plasmids as indicated. Relative expression of alkaline
phosphatase (from ST2 cell RNA), Sox9, Col2A1, and aggrecan
mRNA (from ATDC5 cells) was measured at the time points
shown.
(TIF)
Figure S2 Histologic analysis of long bones. Tibia from
wild type or IKK2ca heterozygote (Het) were processed for
histology and sections were immunostained with H&E (not shown)
or tartrate-resistant acid phosphatase (TRAP) to detect osteoclasts.
Number of osteoclasts per bone surface area (N.OCs/BS) from
WT and Het sections is depicted.
(TIF)
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